Pharmacies RUN OUT Of Crucial Drugs Across Country!

Some patients in the UK are being turned away from pharmacies empty-handed — not for obscure experimental drugs, but for cancer treatments, epilepsy medication, blood pressure pills, and painkillers.

Story Snapshot

87% of UK pharmacy staff now face medicine supply problems every single day, up from 67% in 2022.
73% of pharmacy teams say shortages are putting patient health at direct risk, with some patients unable to access critical drugs at all.
Over 80 different medicines across more than 30 therapy areas have been caught up in shortages, including cancer, epilepsy, and heart drugs.
One in four pharmacy teams spends more than two hours a day just trying to find alternatives for patients — time stolen from actual care.

This Is Not a New Problem — It Just Keeps Getting Worse

Medicine shortages in the UK are not a new story. But the numbers keep moving in the wrong direction. Community Pharmacy England’s 2025 Medicines Supply Report found that 87% of pharmacy staff face daily supply problems, up sharply from 67% three years ago. ^[2] The All-Party Parliamentary Group on pharmacy called shortages “increasingly severe, persistent, and disruptive” — worsening over the past 18 to 24 months. ^[1] That is not a blip. That is a trend.

The Royal Pharmaceutical Society found patients struggling to source over 80 different medicines across more than 30 therapy areas in a single year. ^[3] Nearly 90% of those patients said they had trouble getting the same medicine more than once. Almost half reported problems on more than four separate occasions. ^[3] This is not a one-time inconvenience. For people managing epilepsy or cancer, a missed dose is not just frustrating — it can be dangerous.

Patients Are Paying the Price in Real Time

The human cost is not abstract. The All-Party Parliamentary Group report confirmed that some patients who could not access drugs in short supply have died. ^[1] Others are being pushed toward second-line treatments — drugs that work less well, carry more side effects, or simply are not what their doctor prescribed. Pharmacists are not withholding medicine out of policy preference. They genuinely do not have it on the shelf.

Patients are also being forced to pay privately for drugs that should be covered by the National Health Service, according to pharmacists cited in news coverage. ^[5] That is a direct financial hit on people who are already sick. A system that forces a cancer patient or someone with epilepsy to choose between going without medication and paying out of pocket has broken something fundamental about the promise of public healthcare.

Why Shelves Are Empty: A Problem With Many Fathers

No single cause is driving these shortages. Research into UK drug shortages points to a long list of contributing factors: manufacturing delays, raw material shortages, product recalls, wholesaler problems, Brexit trade disruption, the economic fallout from the COVID-19 pandemic, and geopolitical instability including the war in Ukraine and conflict in the Middle East. ^[8] In high-income countries, low medicine prices — especially for generic drugs — make it harder for manufacturers to justify investment in production capacity. ^[6] When margins are thin, the supply chain becomes fragile.

🔴 NHS faces record drug shortages; Creon, HRT, painkillers in short supply

The National Pharmacy Association and Royal College of GPs warned of "the most severe" medicine shortages on record in the UK, affecting common painkillers, epilepsy drugs, and hormone replacement… pic.twitter.com/MLL3U7VRqT

— NewsTongue (@NewsTongueX) June 18, 2026

The UK also competes in a global market for medicines. When demand spikes elsewhere, or when a key ingredient becomes scarce worldwide, British pharmacies feel it. The government has issued Serious Shortage Protocols for specific drugs including antibiotics and pancreatic enzyme replacement therapy, but even those official measures have not stopped supply problems from reaching patients. ^[2] The system has tools to respond. It is just not responding fast enough.

The Counter-Argument Has Real Limits

Some context is worth keeping. Office for National Statistics data from August 2024 found that among adults who had trouble getting a prescription, 40% had it resolved the same or next day, and 36% within three to four days. ^[3] That matters. It means many access problems are short-lived or local rather than a total national collapse. The Royal Pharmaceutical Society also notes that national teams work with manufacturers and wholesalers to absorb many shortages before they reach patients at all. ^[3] The system does catch some problems before they land.

But that defense only goes so far. A shortage resolved in three days is still a missed dose for a patient with epilepsy. A workaround found by a pharmacist after two hours of phone calls is still two hours not spent on patient care. The counter-argument works best for minor, short-lived disruptions. It does not explain away 73% of pharmacy teams saying patient health is at risk, or the documented deaths linked to inaccessible drugs. ^[1]^[2] The evidence for real harm is stronger than the evidence that the system is managing well.

What Needs to Happen

Community Pharmacy England is calling for structural reforms: stronger supply chain resilience, more flexibility for pharmacists to manage shortages without jumping through regulatory hoops, and fairer payment for the extra work pharmacies are absorbing. ^[2] The All-Party Parliamentary Group has pushed for expanding domestic manufacturing so the UK is less dependent on global supply chains that can fracture under pressure. ^[1] Both are reasonable asks. A country that cannot reliably supply blood pressure medication or epilepsy drugs to its own citizens has a supply chain problem worth treating as a national priority — not a background inconvenience.